178 related articles for article (PubMed ID: 32324697)
1. Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.
Daneshdoost SM; El Abiad JM; Ruble KJ; Jones LC; Crane JL; Morris CD; Levin AS
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e365-e370. PubMed ID: 32324697
[TBL] [Abstract][Full Text] [Related]
2. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
4. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates in multiple myeloma: an updated network meta-analysis.
Mhaskar R; Kumar A; Miladinovic B; Djulbegovic B
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003188. PubMed ID: 29253322
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes.
Nguyen T; Zacharin MR
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):161-7. PubMed ID: 16562590
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate for spontaneous osteonecrosis of the knee: A protocol for systematic review and meta-analysis of randomized controlled trials.
Shen Z; Chen Z; Xie Z; Xu Y; Wang T; Li J; Yuan C; Liu J; Shi X; Ai Y; Dong W; Guo Y
Medicine (Baltimore); 2020 Dec; 99(49):e23123. PubMed ID: 33285686
[TBL] [Abstract][Full Text] [Related]
11. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?
Amin NL; James RM; Phillips R
Arch Dis Child; 2016 Mar; 101(3):287-90. PubMed ID: 26768828
[No Abstract] [Full Text] [Related]
12. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
14. The use of bisphosphonate in the treatment of avascular necrosis: a systematic review.
Cardozo JB; Andrade DM; Santiago MB
Clin Rheumatol; 2008 Jun; 27(6):685-8. PubMed ID: 18270760
[TBL] [Abstract][Full Text] [Related]
15. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
[TBL] [Abstract][Full Text] [Related]
16. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
Jayasena A; Atapattu N; Lekamwasam S
Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for advanced prostate cancer.
Macherey S; Monsef I; Jahn F; Jordan K; Yuen KK; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006250. PubMed ID: 29278410
[TBL] [Abstract][Full Text] [Related]
18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.
Leblicq C; Laverdière C; Décarie JC; Delisle JF; Isler MH; Moghrabi A; Chabot G; Alos N
Pediatr Blood Cancer; 2013 May; 60(5):741-7. PubMed ID: 23002054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]